discuss

Catalent to Discuss the Future of Cell and Gene Therapy Manufacturing at World Orphan Drug Congress Europe

SOMERSET, N.J. (PRWEB) November 05, 2019
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced it will present at the upcoming World Orphan Drug Congress Europe, being held at Hotel Sofia, Barcelona, Spain on Nov. 12 – 14, 2019.
On Wednesday, Nov. 13 at 3:20 p.m., Philip Wills, Ph.D., Chief Commercial Officer, Paragon Gene Therapy (part of Catalent Biologics) will present “Capacity Crunch? The Future of Manufacturing Within Cell & Gene Therapy” as part of the manufacturing track. Dr. Wills’ presentation will highlight the challenges that the gene therapy sector faces in scale-up and manufacturing, driven by the rising numbers of clinical trials and FDA approvals, coupled with low product yields and rising treatment costs. These factors have led to an increased demand for process expertise and manufacturing capacity, and Dr. Wills will address the capacity limitations and discuss the future of cell and gene therapy manufacturing.
Also, on Wednesday, at 2:20 p.m., Stephen Tindal, Director, Science & Technology and Gavin Yates, Program Director, Clinical Supply Services and Drug Product Technologies Integrations, will discuss the benefits of contracting with a single, integrated provider in their presentation, “Next Exit, Success: Get from Concept to Clinic Faster on the Product Development Superhighway.” In the presentation, Mr. Tindal and Mr. Yates will highlight opportunities to streamline and shorten product development timelines.
Dr. Wills has almost two decades of contract manufacturing experience, primarily focused in viral vectors and other complex biologics. He joined Paragon in 2002 where he has since held positions of increasing scope and responsibility, including as Principal Scientist and Vice President of Business Development. He received a bachelor’s degree in chemistry from John Hopkins University, Baltimore, Maryland, and a doctorate in pharmacology from University of Maryland Medical School, Maryland.
Mr. Tindal has worked in softgel R&D for more than 30 years and has broad expertise in this technology. He specializes in root cause investigation, technology innovation, gelatin innovation, and plays a key role in customer liaison and supporting business development. Mr. Tindal holds a bachelor’s degree in chemistry and analytical science from Loughborough University, U.K.
Mr. Yates has more than 15 years’ experience in the pharmaceutical industry. His areas of expertise include project management, packaging and labeling, operational activity, supply chain management and key performance indicator (KPI) analysis. He received his bachelor’s degree in biological sciences from University of Birmingham, U.K.
For more information, visit https://www.catalent.com/index.php/news-events/events/World-Orphan-Drug-Congress-Europe.
To arrange a meeting with any of the attending Catalent experts at the event, contact Richard Kerns at NEPR – richard@nepr.agency.
About CatalentCatalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs nearly 13,000 people, including over 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com.
More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Stevens & Goldwyn, P.A. Discuss the Purpose of HOA (Homeowners' Association ) Attorneys

Press Release – updated: Oct 31, 2019 22:00 EDT

FORT LAUDERDALE, Fla., October 31, 2019 (Newswire.com) – ​​​An HOA is also called a Homeowners Association, which represents the interests of an organized community or condominium. This system can at times feel more like a burden, though, when the HOA fee imposes constraints on a community’s residents. The HOA’s regulating board is basically made up of volunteers from the community who are performing their best to understand the procedures, understandably, they are not always effective.
As HOA staff may need assistance with the clarification and application of tasks, as well as to determine specific legal arguments with respect to individual homeowners, an HOA may appoint an attorney. For example, homeowners will need an attorney to formulate legal papers or negotiate with outside parties like contractors or vendors.
Importance Of HOA Attorneys
Retaining an attorney is generally a good idea for homeowners associations. As legal corporations, associations are legally obliged by their regulating documents and state, local and federal laws. Such regulating papers may be difficult to understand and lawyers can help decipher the more esoteric terms. Attorneys can also assist in homeowner collections, in the case that special assessments are not collected sufficiently from the owner(s). The collections procedure can be managed by a lawyer at the direction of the board of directors, as stipulated by the governing documents.
The HOA bylaws governing documents also determine the fiduciary duties of the board of managers. If a board is determined to not be maintaining these responsibilities or acting carelessly, an attorney can help defend the board or help with litigation. ​​
HOAs Appoint Attorneys to Garner Assessments and Fees
An HOA attorney sometimes is appointed to garner outstanding assessments and fees from homeowners. Having an attorney impose collections enhances the probability of collection, as a lawyer will understand the processes for imposing liens and court judgments associated with nonpayment.
About Stevens & Goldwyn: The homeowners’ association attorneys at Stevens & Goldwyn, P.A. are experts in condominium law, contractual disputes, and HOA litigation. They specialize in representation for homeowners associations, assessment collection, foreclosures, civil litigation and more. Stevens & Goldwyn, P.A. is located in Plantation, Florida, and provides services throughout Florida, including Fort Lauderdale, Miami, Palm Beach, Plantation, Pembroke Pines, Miami Beach, Pompano Beach, Hollywood, Aventura and more.
Arrange a free, no-obligation consultation to discuss any legal concerns with a partner of our firm. Stevens & Goldwyn, P.A. looks forward to answering questions and seeing how they can meet any legal needs. Call us at 954-476-2680 or contact us online today.
Source: Stevens & Goldwyn, P.A.

Catalent to Discuss Accelerating Development in Biologics and Gene Therapies as well as Oral Outsourcing Market Trends at CPhI Worldwide

SOMESET, N.J. (PRWEB) October 29, 2019
Catalent (stand 121A82), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced a busy conference program at the forthcoming CPhI Worldwide annual conference, being held at the Messe Frankfurt, Frankfurt, Germany, on Nov. 5 – 7, 2019.
On Tuesday, Nov. 5 at 10:30 a.m., Jeremie Trochu, Vice President, Operations, Oral Drug Delivery, will participate in a panel session titled “Exploring Trends in Contract Manufacturing”. Panelists will discuss market trends that are currently impacting contract development and manufacturing organizations (CDMOs), and how CDMOs have evolved their strategies to meet the unmet needs of the industry, as well as drive growth.
On Wednesday, Nov. 6 at 10:30 a.m., during the “Understanding the Cell & Gene Technology Opportunity” panel session, Thomas VanCott, Ph.D., Chief Technology & Strategy Officer, Paragon Gene Therapy (part of Catalent Biologics), will discuss ways in which CDMOs can create the correct infrastructure to support innovation, and the sector’s commercialization and pricing challenges. Dr. VanCott will also discuss the various investment opportunities offered by the cell and gene therapy sector.
During the BioProduction conference, on Thursday, Nov. 7 at 12:20 p.m., Melanie Lasher, Manager, Project Management, Catalent Biologics will present “Beating the Clock: Case Studies in Accelerating Biologic Development” in the conference’s “Manufacturing Strategies & Bioprocessing 4.0” stream. Using case studies, Ms. Lasher will highlight and discuss how previous challenges to reduce scheduling delays and accelerate timelines were overcome in projects progressing from cell line development to clinical trial supply.
Mr. Trochu joined Catalent in 2012, following 10 years at General Electric where he held several commercial leadership positions within its healthcare division. His current role sees him lead Catalent’s global oral solid pharmaceutical development services. Mr. Trochu received a master’s degree in international management from Emlyon Business School, Écully, France.
Dr. VanCott joined Paragon following 14 years as the President and CEO of Advanced Bioscience Laboratories, Inc. (ABL). Before joining ABL, he held several positions at the Henry M. Jackson Foundation for the Advancement of Military Medicine. Dr. VanCott received a doctorate in physical chemistry from the University of Virginia, Charlottesville, Virginia, and a bachelor’s degree in chemistry from Dickinson College, Carlisle, Pennsylvania.
Ms. Lasher has more than 10 years’ experience in the biopharma industry. She has managed a variety of clinical, process and performance qualification, and commercial projects, supporting drug substance manufacturing, drug product filing, and packaging. Ms. Lasher received a bachelor’s degree in management from Indiana Wesleyan University, Marion, Indiana, and is a certified Project Management Professional.
At the conference, Catalent will also be exhibiting and showcasing its multiple innovative technologies, including its OneBio platform, which has been shortlisted for a CPhI Excellence in Pharma Award, in the “Contract Services and Outsourcing” category. The winners will be announced at a gala dinner on Tuesday, Nov. 5.
Earlier that day and on Wednesday Nov. 6 at 4 p.m., Catalent will host a networking reception on their stand. For more information visit stand 121A82 or http://www.catalent.com.
To arrange a meeting with any of the attending Catalent experts at the event, contact Richard Kerns at NEPR – richard@nepr.agency.
About CatalentCatalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs nearly 13,000 people, including approximately 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Man who inherited private JFK and RFK papers makes rare speaking appearance to discuss why evidence dismantles official government reports on assassination

Author Christopher Fulton

DALLAS (PRWEB) October 28, 2019
Christopher Fulton, a successful American developer in Vancouver, Canada, was labeled a threat to U.S. national security, placed on the FBI’s most wanted list, arrested, extradited, and interrogated without counsel; he was then viciously prosecuted and federally incarcerated. Christopher Fulton is the last survivor of the U.S. government’s ongoing attempt to finalize the suppression of Robert Kennedy’s unsecured evidence from JFK’s assassination, as detailed in the book, The Inheritance.
Christopher Fulton unwittingly unlocked some of the mysteries that have surrounded JFK’s life and death for more than 55 years when he acquired personal items JFK’s secretary, Evelyn Lincoln, had kept locked away for years, at the request of Robert Kennedy. These included JFK’s secret Oval Office recordings.
These non-secured materials, including a Cartier watch JFK had on at the time of his assassination, had the ability to alter the course of U.S. politics and history, according to Mr. Fulton. Following Mrs. Lincoln’s passing and the transfer of these materials to Mr. Fulton and his subsequent meeting with JFK Jr. who had plans to acquire the evidence and expose the truth about JFK’s death, the U.S. Government intervened, and put Christopher Fulton right in the middle of the Assassination Records Review Board’s investigation under President Bill Clinton. Though promised by President Donald Trump to be released, the files related to Mr. Fulton’s experience remain sealed or missing.
Now a free man, Christopher Fulton tells his story and how this experience has impacted his professional and family life, how being brutally attacked and incarcerated brought him face-to- face with the nation’s cruel penal system, and how a political agenda can overrule justice. While there is much discussion in the nation about a “Deep State”, Christopher believes he came up against it by accidentally, opening a hidden chapter in U.S. history.
ABOUT CHRIS FULTON: Christopher Fulton was born in 1965, just outside Washington, D.C., into a family with rich military history. He was on his way to being accepted to the U.S. Naval Academy at Annapolis but chose a career in commercial construction. His discipline and diligence took him to the top of the high-rise construction industry in Vancouver, British Columbia, where at age 33, during the height of his success, he was extradited and spent years in federal prison for his possession of the physical evidence related to JFK’s assassination. His wife, Michelle Fulton, helped him write a memoir of the experience, called The Inheritance: Poisoned Fruit of JFK’s Assassination (Trine Day, ISBN#: 978-1-63424- 217- 2). The Fultons reside in California with their two children and rescue dogs.
For more information or interviews:Kris Millegan (800) 556-2012; ramillegan@aol.comJulia W. Brown (619) 888-7956

Share article on social media or email:

Worldwide Business with kathy ireland®: See Condair Discuss Their Innovative Indoor Air Hydration Solutions

Worldwide Business with kathy ireland® and Condair

Worldwide Business with kathy ireland® is pleased to announce an exclusive interview with Condair Switzerland CEO Oliver Zimmerman and Consultant Dr. Stephanie Taylor to discuss their revolutionary humidifiers that enhance indoor air quality.

LOS ANGELES (PRWEB) October 26, 2019
Worldwide Business with kathy ireland® is pleased to announce an exclusive interview with Condair Switzerland CEO Oliver Zimmerman and Consultant Dr. Stephanie Taylor to discuss their revolutionary humidifiers that enhance indoor air quality.
Condair is the leading manufacturer and provider of complete solutions in the areas of humidification and evaporative cooling. The company has a comprehensive portfolio including products, services, experience and know-how. This enables Condair to create the ideal indoor climate while keeping energy consumption low and reducing impact on the environment. Condair is passionate about sharing and developing only the best solutions for humidity and environmentally-conscious evaporative control. Exposure to dry air in a home or work environment can cause discomfort and can also lead to skin and eye irritation, hair damage, respiratory problems and subsequent infections. It can also negatively impact a home by negating proper static electricity dissipation, which can lead to a risk of static shock, as well as potential damage to wooden floors and structural components (because dry air can pull moisture away from the structure of a home). With proper humidification from Condair, these effects can be minimized and, in many cases, eliminated. Condair has developed a comprehensive suite of humidification systems that enable for properties of all sizes to introduce efficient and consistent hydration and comfort control. Condair was founded in 1948 and is headquartered in Pfäffikon/SZ near Zurich, Switzerland
Zimmerman says that nearly anyone — and any building — can benefit from Condair. He explains, “When you think back in history, for thousands of years, mankind lived in spaces with an open architecture. There was a natural exchange of air and therefore also good natural humidity. And then, about three-hundred years ago with the Industrial Revolution, we started spending our time more and more indoors. And now, we spend eighty to ninety percent of our time indoors. Nowadays, we have tight building envelopes. There is less and less air exchange. Therefore, almost any building needs humidity.” For more information about Condair’s humidifiers and air hydration solutions, visit Condair.com and tune in to Fox Business Network as sponsored content on Sunday, October 27, 2019 at 5:30pm EST.
About Worldwide Business with kathy ireland®Worldwide Business with kathy ireland® is a weekly half-hour show featuring global executives sharing their business insights and framing the opportunities shaping their industries. Hosted by a business mogul, Kathy Ireland interviews some of the brightest minds in business today. The show broadcasts on Fox Business Network as part of their sponsored content line up and internationally on Bloomberg Television. Worldwide Business with kathy ireland® extends beyond the weekly on-air program with digital content delivered on various video platforms and across social media.
Visit http://www.wwbki.com for detailed airing schedules or check local listings.

Share article on social media or email: